Braun Stacey Associates Inc. Sells 138,490 Shares of Itron, Inc. $ITRI

Braun Stacey Associates Inc. decreased its holdings in Itron, Inc. (NASDAQ:ITRI) by 67.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 67,429 shares of the scientific and technical instruments company’s stock after selling 138,490 shares during the quarter. Braun Stacey Associates Inc. owned about 0.15% of Itron worth $6,261,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also added to or reduced their stakes in the stock. Palisades Investment Partners LLC raised its holdings in Itron by 1.8% in the 4th quarter. Palisades Investment Partners LLC now owns 75,006 shares of the scientific and technical instruments company’s stock worth $6,965,000 after purchasing an additional 1,359 shares in the last quarter. Harbor Capital Advisors Inc. boosted its stake in shares of Itron by 17.4% during the 4th quarter. Harbor Capital Advisors Inc. now owns 15,446 shares of the scientific and technical instruments company’s stock valued at $1,434,000 after purchasing an additional 2,293 shares in the last quarter. Formidable Asset Management LLC purchased a new position in shares of Itron during the fourth quarter valued at about $392,000. Tema Etfs LLC raised its stake in Itron by 88.6% in the fourth quarter. Tema Etfs LLC now owns 96,566 shares of the scientific and technical instruments company’s stock worth $8,967,000 after buying an additional 45,360 shares in the last quarter. Finally, J. Safra Sarasin Holding AG raised its stake in Itron by 25.0% in the fourth quarter. J. Safra Sarasin Holding AG now owns 46,909 shares of the scientific and technical instruments company’s stock worth $4,356,000 after buying an additional 9,390 shares in the last quarter. Institutional investors own 96.19% of the company’s stock.

Analysts Set New Price Targets

Several analysts have weighed in on ITRI shares. Needham & Company LLC initiated coverage on Itron in a research report on Friday, March 6th. They set a “buy” rating and a $124.00 price objective on the stock. Guggenheim set a $155.00 target price on Itron in a research report on Friday, February 13th. Wall Street Zen cut Itron from a “buy” rating to a “hold” rating in a research note on Wednesday, January 14th. Oppenheimer upped their price target on Itron from $125.00 to $133.00 and gave the stock an “outperform” rating in a research note on Wednesday, February 18th. Finally, Weiss Ratings downgraded Itron from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday, January 12th. Eight investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $137.10.

Insiders Place Their Bets

In other news, SVP Donald L. Reeves III sold 519 shares of the stock in a transaction on Wednesday, February 25th. The stock was sold at an average price of $97.84, for a total value of $50,778.96. Following the sale, the senior vice president directly owned 29,951 shares of the company’s stock, valued at approximately $2,930,405.84. This represents a 1.70% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, SVP Laurie Ann Pulatie-Hahn sold 729 shares of Itron stock in a transaction dated Friday, February 20th. The stock was sold at an average price of $100.17, for a total value of $73,023.93. Following the completion of the transaction, the senior vice president directly owned 32,950 shares of the company’s stock, valued at approximately $3,300,601.50. This represents a 2.16% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 51,180 shares of company stock valued at $5,085,475. Company insiders own 1.45% of the company’s stock.

Itron Price Performance

Shares of NASDAQ ITRI opened at $88.69 on Friday. The company has a 50 day simple moving average of $94.84 and a two-hundred day simple moving average of $103.51. Itron, Inc. has a fifty-two week low of $83.51 and a fifty-two week high of $142.00. The company has a market capitalization of $3.93 billion, a price-to-earnings ratio of 13.62, a P/E/G ratio of 0.77 and a beta of 1.50. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.56 and a current ratio of 1.80.

Itron (NASDAQ:ITRI) last posted its quarterly earnings results on Tuesday, February 17th. The scientific and technical instruments company reported $2.46 earnings per share for the quarter, topping the consensus estimate of $2.19 by $0.27. Itron had a return on equity of 20.04% and a net margin of 12.72%.The company had revenue of $571.66 million for the quarter, compared to the consensus estimate of $561.31 million. During the same quarter in the prior year, the business posted $1.35 EPS. The firm’s quarterly revenue was down 6.7% compared to the same quarter last year. Itron has set its Q1 2026 guidance at 1.200-1.300 EPS and its FY 2026 guidance at 5.750-6.250 EPS. Analysts expect that Itron, Inc. will post 5.33 EPS for the current fiscal year.

Itron Profile

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.